Company Information

Cannasouth Limited is the parent company and 100% owner of subsidiary companies:

  • Cannasouth Bioscience Limited
  • Cannasouth Cultivation Ltd
  • Midwest Pharmaceutics NZ Ltd

The Cannasouth Group has been established to focus on the commercial development of the medicinally beneficial attributes of cannabinoid compounds such as CBD, THC and associated chemical structures that are produced by the cannabis plant. Our goal is the development of next-generation cannabinoid medicines that support patients’ health outcomes and improve their quality of life. Our products will be produced under GxP using environmentally friendly methods without the use of harmful chemicals or solvents, ensuring patients are treated with pure cannabinoid therapeutic compounds of the highest quality.

Registered Office
c/- Braithwaite and Pearks Limited
240 Victoria Street
Floor 1
Hamilton Central
Hamilton, 3204
New Zealand

Head Office
Level 2, CRV Building
Waikato Innovation Park
2 Melody Lane
Hamilton East, 3216
New Zealand

Phone: +64 7 949 8393
Financial Year End: December 31 each year

A short overview of Cannasouth’s history, milestones, and management team.

Cannasouth Fact Sheet